U.S. Specialty Stores Stock News

NYSE:PCOR
NYSE:PCORSoftware

Is It Time To Reassess Procore Technologies (PCOR) After Its Recent Share Price Pullback

If you are wondering whether Procore Technologies at around US$49.60 is starting to look interesting, the key question is how that price compares with the value of the underlying business. The stock has recently pulled back, with returns of an 11.3% decline over 7 days, a 13.2% decline over 30 days, and a 29.2% decline year to date, contributing to an 18.2% decline over the past year. These moves come as Procore continues to attract attention as a construction software platform, with...
NYSE:FBK
NYSE:FBKBanks

FB Financial (FBK) Net Interest Margin Holds Near 3.9% Challenging Cost Concern Narratives

FB Financial (FBK) has put up a clean set of Q1 2026 numbers, with revenue of US$169.3 million and basic EPS of US$1.11, setting the tone against a trailing twelve month backdrop of US$557.7 million in revenue and EPS of US$2.76. Over recent quarters, revenue has moved from US$128.4 million in Q1 2025 to US$169.3 million in Q1 2026, while quarterly EPS has shifted from US$0.84 to US$1.11, giving you a clearer run rate to judge how sustainable current profitability and margins might be. See...
NasdaqGM:RENT
NasdaqGM:RENTSpecialty Retail

Rent The Runway (RENT) Q3 Profit Swing Challenges Balance Sheet Bear Narratives

Rent the Runway (RENT) just posted a sharp swing in its latest FY 2026 third quarter numbers, reporting revenue of US$87.6 million and basic EPS of US$13.69 on net income of US$76.5 million. Earlier quarters in the same fiscal year showed losses at both the EPS and net income line. Over recent periods, revenue has moved from US$75.9 million in Q3 2025 to US$76.4 million in Q4 2025, then to US$69.6 million in Q1 2026, US$80.9 million in Q2 2026 and now US$87.6 million. Basic EPS shifted from a...
NasdaqGS:NFE
NasdaqGS:NFEOil and Gas

New Fortress Energy (NFE) Deep FY 2025 EPS Loss Tests Bullish LNG Growth Narrative

New Fortress Energy (NFE) closed out FY 2025 with Q4 revenue of US$415.9 million and a basic EPS loss of US$2.77, alongside a net income loss of US$788.4 million. Over the last six reported quarters, revenue has ranged from US$301.7 million to US$668.2 million, while basic EPS has swung between a small profit of US$0.03 and a loss of US$2.77. This gives investors a wide view of how top line scale and per share losses have moved together. With trailing 12 month revenue at about US$1.5 billion...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Is It Too Late To Consider Dyne Therapeutics (DYN) After A 152% One‑Year Surge?

If you are wondering whether Dyne Therapeutics at around US$19.81 is still offering value or has already priced in much of the story, the next sections aim to put the current share price in context. The stock has recently posted returns of 9.1% over 7 days, 10.5% over 30 days, 7.1% year to date and 152.4% over the past year, which can change how investors see both its potential and its risks. Recent news flow around Dyne Therapeutics has centered on its progress as a biotechnology name and...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

Is It Too Late To Consider Star Bulk Carriers (SBLK) After Its 78.8% One Year Rally?

If you are wondering whether Star Bulk Carriers is priced attractively or already reflects its potential, this article breaks down what the current share price could mean for you as an investor. At a last close of US$24.73, the stock has returns of 2.6% over 7 days, 13.2% over 30 days, 27.7% year to date and 78.8% over 1 year. These recent moves are front of mind when thinking about value and risk. Recent coverage has focused on Star Bulk Carriers within the broader shipping sector,...
NYSE:SLGN
NYSE:SLGNPackaging

Has Silgan Holdings (SLGN) Share Price Weakness Opened Up A Valuation Opportunity?

Wondering whether Silgan Holdings at around US$41.87 is priced for opportunity or caution? This article breaks down what the current share price could be implying about value. The stock is up 6.1% over the last 7 days and 0.6% over the past month, yet year to date it is only up 1.5%, and the 1 year return sits at a 14.0% decline. That mix of recent gains and a weaker 1 year and 3 year record, with returns of a 14.0% decline and 16.2% decline respectively, has kept Silgan on the radar for...
NYSE:OII
NYSE:OIIEnergy Services

Is It Too Late To Consider Oceaneering International (OII) After A 120% One Year Rally?

Wondering if Oceaneering International at around US$37.43 is offering fair value or if the market is getting ahead of itself? This article walks you through the key signals that can help you answer that question. The stock has delivered returns of 2.3% over the last 7 days, 12.5% over 30 days, 50.6% year to date and 120.4% over the past year, with 3 year and 5 year returns of 105.8% and 245.6% respectively. This naturally raises questions about what is already priced in. Recent attention on...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Is It Too Late To Consider ImmunityBio (IBRX) After Its 261% Year To Date Surge?

Wondering if ImmunityBio at around US$7.30 is still priced for opportunity or already reflecting the story most investors see? This article is built to help you frame that question clearly. The stock has delivered a 261.4% return year to date and 162.6% over the past year. However, the last 30 days show a 13.0% decline and the last week a 6.4% gain, which can change how you think about both potential and risk. Recent coverage of ImmunityBio has focused on how its clinical pipeline and...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum’s Artemis II Role Highlights Mission Critical Space And Defense Ambitions

Amentum Holdings (NYSE:AMTM) played an essential role in NASA's Artemis II mission, the first crewed launch of the Artemis program. The company supported ground systems operations, critical launch support, safety systems deployment, and post mission recovery of the Orion spacecraft. This work contributes to NASA's goal of a sustained lunar presence and future deep space missions. Amentum operates as a mission critical engineering and operations partner to US government agencies and other...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

Is Byrna Technologies (BYRN) Trading Online Margins for Brick‑and‑Mortar Reach?

Byrna Technologies Inc. has reported past first‑quarter 2026 results showing sales rising to US$29.05 million while net income fell to US$0.80 million, reducing earnings per share versus the prior year. The new CEO outlined a push toward brick‑and‑mortar and dealer growth amid weaker ecommerce conversion, as analysts adjusted their views on the company’s prospects. Now we’ll explore how weaker online conversion but growing retail channels may reshape Byrna’s existing investment narrative and...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

Top Growth Companies With Strong Insider Ownership April 2026

Over the last 7 days, the United States market has risen by 4.2%, contributing to a significant 29% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with substantial insider ownership can be particularly appealing as they often signify strong confidence from those closely involved in their operations.
NasdaqGM:CERS
NasdaqGM:CERSMedical Equipment

Oramed Pharmaceuticals And Two Other Promising Penny Stocks For Savvy Investors

The market has shown impressive growth, with a 4.2% increase over the last week and a 29% rise over the past year, while earnings are projected to grow by 16% annually. Although the term 'penny stock' may seem outdated, it still represents an area of investment that can uncover significant opportunities in smaller or newer companies. By focusing on those with strong financials and clear growth potential, investors can find hidden value in quality penny stocks that offer both stability and...
NYSE:VICI
NYSE:VICISpecialized REITs

Dividend Stocks To Consider In April 2026

The United States market has shown impressive strength, climbing 4.2% over the last week and achieving a remarkable 29% increase over the past year, with earnings projected to grow by 16% annually. In this thriving environment, dividend stocks that offer consistent payouts and potential for growth can be appealing options for investors seeking to enhance their portfolios.
NYSE:HOMB
NYSE:HOMBBanks

Assessing Home BancShares (HOMB) Valuation After Recent Share Price Momentum

Recent performance snapshot for Home BancShares Home BancShares (HOMB) shares have quietly moved higher over the past month, with recent returns of 7.3% for that period and 1.1% year to date. This has prompted a closer look at the bank’s fundamentals. See our latest analysis for Home BancShares. The recent 7.3% 30 day share price return and 12.6% 1 year total shareholder return suggest momentum has been improving, even though the 90 day share price return of 0.6% looks more muted. If this...
NYSE:BTU
NYSE:BTUOil and Gas

Peabody Energy Faces Centurion Setback Testing Met Coal Growth Story

Peabody Energy (NYSE:BTU) reported that first quarter sales volumes at its Centurion mine in Australia are below prior expectations. The shortfall stems from greater than anticipated commissioning challenges at the new operation. Following this update, an analyst reduced the price target on Peabody Energy shares. Peabody Energy is a large coal producer with operations across the United States and Australia, and the Centurion mine is one of its key new Australian assets. Commissioning issues...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Domino’s New Italiano Range Tests Premium At Home Pizza Demand

Domino's Pizza (NasdaqGS:DPZ) is launching a new Italian inspired pizza range with a thinner crust. The Italiano line targets customers looking for a more premium, restaurant style experience at home. The move shifts the menu mix toward higher end offerings, beyond the chain's traditional core products. For investors following NasdaqGS:DPZ, this new Italiano range sits at the intersection of fast food and at home dining. Pizza chains continue to test product lines that speak to changing...
NYSE:AORT
NYSE:AORTMedical Equipment

Assessing Artivion (AORT) Valuation After FDA Approval Of NEXUS Aortic Arch System

Artivion (AORT) is back in focus after the FDA approved the NEXUS Aortic Arch System, a minimally invasive device for aortic arch disease that also activates the company’s option to acquire developer Endospan. See our latest analysis for Artivion. The FDA approval appears to have revived interest in Artivion, with a 7 day share price return of 15.31% and a 1 day move of 2.50% lifting the stock to $38.57. However, the 1 year total shareholder return of 66.75% contrasts with weaker year to date...
NYSE:TGLS
NYSE:TGLSBuilding

Is Tecnoglass (TGLS) Pricing Look Attractive After A 35% One-Year Share Price Decline

This article examines whether Tecnoglass is attractively priced or a potential value trap at its current level by walking through what the latest data indicates about the stock's valuation. The share price last closed at US$45.74, with returns of 4.7% over the past week, 0.1% over the past month, a 12.1% decline year to date, and a 35.6% decline over the last year, compared with an 8.2% three year return and a 274.0% return over five years. Recent pricing moves sit alongside ongoing investor...
NasdaqCM:OBT
NasdaqCM:OBTBanks

3 Undervalued Small Caps With Insider Buying Across Regions

Over the last 7 days, the United States market has risen by 4.2%, contributing to a substantial 29% climb over the past year, with earnings forecasted to grow by 16% annually. In this environment, identifying stocks that are both undervalued and have insider buying can present intriguing opportunities for investors seeking potential growth within small-cap sectors.